ReviewCNS drugs2015
The therapeutic potential of α7 nicotinic acetylcholine receptor (α7 nAChR) agonists for the treatment of the cognitive deficits associated with schizophrenia.
Corinne Beinat et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
35 papers cite it
this papertrialcites it